Company / Cash per Share
ADMA Biologics, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.37
FY2025
5-year range
$0.23 / $0.49
FY2021-FY2025
Trend
-18.8%
vs FY2024
Sector context
#183 of 205
Health Care
What the data says
ADMA Biologics, Inc.'s cash per share of $0.37 is lower than 89% of companies in the Health Care sector (FY2025). Cash per Share has fluctuated over the past 10 years, ranging from $0.23 in FY2023 to $3.35 in FY2017.
Based on SEC 10-K filings.
0.37 in FY2025 with a 5-year CAGR of -17.0%.
Improved from $0.23 to $0.37 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -5.7%
- 5-Year CAGR
- -17.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 205This company $0.37 Sector average $67.98
▼
-99.5% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 18.8% year-over-year.
- Ranks #183 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2017.
- Lowest cash per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.37 | -18.8% |
| FY2024 | $0.46 | +97.1% |
| FY2023 | $0.23 | -47.6% |
| FY2022 | $0.44 | -9.3% |
| FY2021 | $0.49 | -48.3% |
| FY2020 | $0.94 | +63.3% |
| FY2019 | $0.58 | -20.8% |
| FY2018 | $0.73 | -78.2% |
| FY2017 | $3.35 | +261.4% |
| FY2016 | $0.93 | -50.0% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026